News

Tesco slips Tuesday, underperforms market
Tesco PLC closed 1.94% below its 52-week high of £4.08, which the company reached on July 1st.
Sage Group rises Tuesday, outperforms market
Sage Group PLC closed 8.45% short of its 52-week high of £13.49, which the company achieved on February 6th.
Entain climbs Tuesday, outperforms market
Entain PLC hit a new 52-week high, surpassing its previous peak of £9.24, which the company reached on July 7th.
Diageo rises Tuesday, outperforms market
Diageo PLC closed 29.00% below its 52-week high of £27.32, which the company reached on July 16th.
Here’s what the megabill means for retirees’ taxes, according to a financial adviser
Financial adviser Devin Carroll got right to work over the Fourth of July weekend assessing his clients’ tax obligations ...
Here’s why Enphase and other solar stocks are tanking after Trump’s latest move
The maker of solar-power components saw its stock downgraded after Trump’s executive order enforcing a phaseout of tax ...
Home sellers have gotten tired of cutting prices. So they’re yanking their houses off the market.
Home sellers in some of the nation’s worst housing markets are tired of cutting prices. So they’re pulling their listings.
CoreWeave’s stock has quadrupled since the IPO — and that’s just one reason some analysts are cautious
CoreWeave is highly reliant on Microsoft for revenue. Plus, soon insiders will be able to sell shares after the post-IPO ...
I put my $500K inheritance into a joint account with my husband. Can I leave half of it to my son from a previous marriage?
That means two things. First, you could legitimately move half the money into another account for your son, preferably with ...
Circle’s stock should be worth less than half what it is now, analyst says
Mizuho’s Dan Dolev is the third analyst to make a bearish call on Circle Internet’s stock, with a price target that is nearly ...
Is a master’s degree still worth it? These Gen Z grads have seen higher unemployment rates than most.
Fresh debate has emerged online as recent economic data show that many recent graduates — even those with master’s degrees — ...
ProKidney Shares Skyrocket After Favorable Results in Kidney Disease Study
Shares of ProKidney rose 558% after it reported favorable results from a study of its lead drug candidate, rilparencel, in patients with chronic kidney disease and diabetes.